Tetraphenylphosphonium

Tetraphenylphosphonium

SCHEMBL3304548

F.[F-].c1ccc([P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.45
ALDH1A1 P00352 5/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MGLL Q99685 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TSHR P16473 5/20 0.33
DPP4 P27487 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
F2 P00734 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
MAPK1 P28482 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetraphenylphosphonium SCHEMBL585136 0.96 HIF1A (0.47) HIF1AALDH1A1MAPTHPGDSMN1; SMN2
Tetraphenylphosphonium SCHEMBL7906432 0.93 HIF1A (0.45) HIF1AALDH1A1MAPTHPGDSMN1; SMN2
Tetraphenylphosphonium SCHEMBL3300848 0.93 HIF1A (0.45) HIF1AALDH1A1MAPTHPGDSMN1; SMN2
Tetraphenylphosphonium SCHEMBL18936425 0.93 HIF1A (0.45) HIF1AALDH1A1MAPTHPGDSMN1; SMN2
Tetraphenylphosphonium SCHEMBL29362652 0.93 HIF1A (0.50) HIF1AALDH1A1MAPTHPGDSMN1; SMN2
Tetraphenylphosphonium SCHEMBL9547828 0.90 HIF1A (0.43) HIF1AALDH1A1MAPTHPGDSMN1; SMN2
Tetraphenylphosphonium SCHEMBL158514 0.89 HIF1A (0.47) HIF1AALDH1A1MAPTHPGDSMN1; SMN2
Tetraphenylphosphonium SCHEMBL19921940 0.89 HIF1A (0.47) HIF1AALDH1A1MAPTHPGDSMN1; SMN2
Tetraphenylphosphonium SCHEMBL30623276 0.89 HIF1A (0.47) HIF1AALDH1A1MAPTHPGDSMN1; SMN2
Tetraphenylphosphonium SCHEMBL9638111 0.89 HIF1A (0.47) HIF1AALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4780559-A Process for preparing organic fluorides IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-10-25 US claimed
US-20100096585-A1 Process for Preparing 2,6-Dichloro-4-(Trifluoromethyl)Phenylhydrazine Using Mixtures of Dichloro-Fluoro-Trifluoromethylbenzenes BASF SE (DE) 2010-04-22 US disclosed
EP-2137135-A1 PROCESS FOR PREPARING 2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYLHYDRAZINE USING MIXTURES OF DICHLORO-FLUORO-TRIFLUOROMETHYLBENZENES BASF SE (DE) 2009-12-30 EP disclosed
WO-2008113660-A1 PROCESS FOR PREPARING 2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYLHYDRAZINE USING MIXTURES OF DICHLORO-FLUORO-TRIFLUOROMETHYLBENZENES BASF SE (DE) 2008-09-25 WO disclosed
EP-0413464-A2 Catalysts IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-02-20 EP disclosed
EP-0413465-A2 Catalysts IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-02-20 EP disclosed
US-4956428-A POLYMERIZATION OF ACRYLIC OR MALEIMIDE MONOMER WITH ORGANOSILICON, ORGANOTIN, ORGANOGERMANIUM INITIATORS, COORDINATION CATALYST IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-09-11 US disclosed
EP-0329330-A2 Polymerisation process IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-08-23 EP disclosed
EP-0329329-A2 Polymerisation process IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-08-23 EP disclosed
US-4791181-A LOW CONCENTRATIONS OF ACETONITRILE USED TO CONTROL FORMATION OF LIVING POLYMERS BY BULK POLYMERIZATION IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-12-13 US disclosed
US-4780559-A Process for preparing organic fluorides IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-10-25 US disclosed
EP-0278668-A2 Polymerisation process IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-08-17 EP disclosed
EP-0187023-A2 Process for the preparation of organic fluorides IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100096585-A1 Process for Preparing 2,6-Dichloro-4-(Trifluoromethyl)Phenylhydrazine Using Mixtures of Dichloro-Fluoro-Trifluoromethylbenzenes DAZAP1, CYP4Z1, CYP2F1 HIF1A 402/4885ALDH1A1 93/4885MAPT 1980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.